216 related articles for article (PubMed ID: 9682677)
1. CYFRA 21-1, a cytokeratin subunit 19 fragment, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Kanazawa H; Yoshikawa T; Yamada M; Shoji S; Fujii T; Kudoh S; Hirata K; Yoshikawa J
Clin Sci (Lond); 1998 May; 94(5):531-5. PubMed ID: 9682677
[TBL] [Abstract][Full Text] [Related]
2. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.
Vercauteren IM; Verleden SE; McDonough JE; Vandermeulen E; Ruttens D; Lammertyn EJ; Bellon H; De Dycker E; Dooms C; Yserbyt J; Verleden GM; Vanaudenaerde BM; Wuyts WA
Exp Lung Res; 2015; 41(8):459-65. PubMed ID: 26381718
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia.
Dobashi N; Fujita J; Ohtsuki Y; Yamadori I; Yoshinouchi T; Kamei T; Takahara J
Eur Respir J; 1999 Sep; 14(3):574-8. PubMed ID: 10543277
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
5. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of CYFRA 21-1 and ProGRP in serum and bronchoalveolar lavage fluid of patients with benign lung disease].
Matsubara Y; Iwashita T; Ishimatsu Y; Shikuwa C; Kadota J; Kohno S
Nihon Kokyuki Gakkai Zasshi; 2000 Sep; 38(9):659-64. PubMed ID: 11109801
[TBL] [Abstract][Full Text] [Related]
7. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
8. [Studies of serum markers in patients with interstitial pneumonia/pulmonary fibrosis complicated with collagen diseases: clinical evaluation of CYFRA21-1].
Suzuki A; Masuda T; Koito N; Suzuki T; Mita S; Matsuoka Y; Irimajiri S
Ryumachi; 1996 Dec; 36(6):837-43. PubMed ID: 9122823
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
10. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis.
Kucejko W; Chyczewska E; Naumnik W; Ossolińska M
Folia Histochem Cytobiol; 2009; 47(2):225-30. PubMed ID: 19995708
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of cytokeratin fragment 19 (CYFRA 21-1) in bronchoalveolar lavage fluid in lung cancer.
Cremades MJ; Menéndez R; Pastor A; Llopis R; Aznar J
Respir Med; 1998 May; 92(5):766-71. PubMed ID: 9713638
[TBL] [Abstract][Full Text] [Related]
12. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Li J; Chen P; Mao CM; Tang XP; Zhu LR
Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
[TBL] [Abstract][Full Text] [Related]
14. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
[TBL] [Abstract][Full Text] [Related]
15. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease.
Pohl WR; Conlan MG; Thompson AB; Ertl RF; Romberger DJ; Mosher DF; Rennard SI
Am Rev Respir Dis; 1991 Jun; 143(6):1369-75. PubMed ID: 1710880
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
Specks U; Martin WJ; Rohrbach MS
Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
[TBL] [Abstract][Full Text] [Related]
17. Protein C anticoagulant system in patients with interstitial lung disease.
Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
[TBL] [Abstract][Full Text] [Related]
18. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
19. Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases.
Bargagli E; Olivieri C; Prasse A; Bianchi N; Magi B; Cianti R; Bini L; Rottoli P
Inflammation; 2008 Oct; 31(5):351-4. PubMed ID: 18784990
[TBL] [Abstract][Full Text] [Related]
20. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].
Kopiński P; Przybylski G; Jarzemska A; Sładek K; Soja J; Iwaniec T; Balicka-Slusarczyk B; Pinis G; Dyczek A; Szabłowska K; Golińska J; Jankowski M; Szczeklik J
Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
